S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
pixel
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
pixel
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
pixel
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
pixel
Log in
NYSE:CLB

Core Laboratories Stock Forecast, Price & News

$35.82
+0.89 (+2.55 %)
(As of 03/5/2021 12:00 AM ET)
Add
Compare
Today's Range
$34.00
Now: $35.82
$36.26
50-Day Range
$32.92
MA: $34.96
$36.84
52-Week Range
$6.68
Now: $35.82
$38.12
Volume871,962 shs
Average Volume481,099 shs
Market Capitalization$1.60 billion
P/E RatioN/A
Dividend Yield0.12%
Beta3.38
Core Laboratories N.V. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, Canada, and internationally. The company operates in two segments, Reservoir Description and Production Enhancement. The Reservoir Description segment includes the characterization of petroleum reservoir rock, fluid, and gas samples to enhance production and improve recovery of oil and gas from its clients' reservoirs. It offers laboratory-based analytical and field services to characterize properties of crude oil and petroleum products; and proprietary and joint industry studies. The Production Enhancement segment offers services and products relating to reservoir well completions, perforations, stimulations, and production. It offers integrated diagnostic services to evaluate and monitor the effectiveness of well completions and to develop solutions to improve the effectiveness of enhanced oil recovery projects. The company markets and sells its products through a combination of sales representatives, technical seminars, trade shows, and print advertising, as well as through distributors. Core Laboratories N.V. was founded in 1936 and is based in Amstelveen, the Netherlands.
Core Laboratories logo

Headlines

Why Core Laboratories Shares Plunged 11.9% Today
February 23, 2021 |  finance.yahoo.com
Core Laboratories
February 7, 2021 |  fool.com
Core Laboratories (CLB) Q4 2020 Earnings Call Transcript
January 28, 2021 |  finance.yahoo.com
Core Labs' (CLB) Q4 Earnings and Revenues Beat Estimates
January 28, 2021 |  finance.yahoo.com
CLB Feb 2021 25.000 call
January 17, 2021 |  au.finance.yahoo.com
CLB Jan 2021 17.500 put
December 24, 2020 |  au.finance.yahoo.com
CLB Jan 2021 20.000 put
December 23, 2020 |  au.finance.yahoo.com
Why Core Laboratories Stock Sank Today
December 17, 2020 |  fool.com
Is CLB A Good Stock To Buy Now?
December 15, 2020 |  finance.yahoo.com
See More Headlines

Industry, Sector and Symbol

Industry Oil & gas field services, not elsewhere classified
Sub-IndustryN/A
CUSIPN/A
Phone31-20-420-3191
Employees3,700
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$668.21 million
Cash Flow$2.45 per share
Book Value$4.10 per share

Profitability

Net Income$101.98 million

Miscellaneous

Market Cap$1.60 billion
Next Earnings Date4/28/2021 (Estimated)
OptionableOptionable

MarketRank

Overall MarketRank

1.55 out of 5 stars

Oils/Energy Sector

112th out of 668 stocks

Oil & Gas Field Services, Not Elsewhere Classified Industry

7th out of 45 stocks

Analyst Opinion: 1.0Community Rank: 2.1Dividend Strength: 1.7Insider Behavior: 1.7Valuation: 1.3 5 -4 -3 -2 -1 -
$35.82
+0.89 (+2.55 %)
(As of 03/5/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive CLB News and Ratings via Email

Sign-up to receive the latest news and ratings for CLB and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Core Laboratories (NYSE:CLB) Frequently Asked Questions

Is Core Laboratories a buy right now?

12 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Core Laboratories in the last year. There are currently 1 sell rating, 9 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" Core Laboratories stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CLB, but not buy additional shares or sell existing shares.
View analyst ratings for Core Laboratories
or view top-rated stocks.

What stocks does MarketBeat like better than Core Laboratories?

Wall Street analysts have given Core Laboratories a "Hold" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Core Laboratories wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Core Laboratories' next earnings date?

Core Laboratories is scheduled to release its next quarterly earnings announcement on Wednesday, April 28th 2021.
View our earnings forecast for Core Laboratories
.

How were Core Laboratories' earnings last quarter?

Core Laboratories (NYSE:CLB) released its quarterly earnings data on Tuesday, January, 26th. The oil and gas company reported $0.18 earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of $0.16 by $0.02. The oil and gas company had revenue of $113.80 million for the quarter, compared to analysts' expectations of $108.40 million. Core Laboratories had a negative net margin of 19.02% and a positive trailing twelve-month return on equity of 45.39%. Core Laboratories's quarterly revenue was down 27.4% on a year-over-year basis. During the same period in the previous year, the company posted $0.38 earnings per share.
View Core Laboratories' earnings history
.

How has Core Laboratories' stock been impacted by Coronavirus?

Core Laboratories' stock was trading at $10.93 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, CLB shares have increased by 227.7% and is now trading at $35.82.
View which stocks have been most impacted by COVID-19
.

How often does Core Laboratories pay dividends? What is the dividend yield for Core Laboratories?

Core Laboratories announced a quarterly dividend on Friday, January 15th. Shareholders of record on Monday, January 25th will be paid a dividend of $0.01 per share on Tuesday, February 16th. This represents a $0.04 annualized dividend and a yield of 0.11%. The ex-dividend date of this dividend is Friday, January 22nd.
View Core Laboratories' dividend history
.

Is Core Laboratories a good dividend stock?

Core Laboratories pays an annual dividend of $0.04 per share and currently has a dividend yield of 0.12%. Core Laboratories does not yet have a strock track record of dividend growth. The dividend payout ratio of Core Laboratories is 2.23%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Core Laboratories will have a dividend payout ratio of 4.65% next year. This indicates that Core Laboratories will be able to sustain or increase its dividend.
View Core Laboratories' dividend history.

What price target have analysts set for CLB?

12 brokerages have issued 12 month price targets for Core Laboratories' shares. Their forecasts range from $11.00 to $30.00. On average, they expect Core Laboratories' stock price to reach $21.22 in the next twelve months. This suggests that the stock has a possible downside of 40.8%.
View analysts' price targets for Core Laboratories
or view top-rated stocks among Wall Street analysts.

Who are Core Laboratories' key executives?

Core Laboratories' management team includes the following people:
  • Mr. Lawrence V. Bruno, Chairman, CEO, Pres & COO (Age 61, Pay $1.28M)
  • Mr. Christopher Scott Hill, Sr. VP & CFO (Age 51, Pay $448.02k)
  • Mr. Kevin G. Daniels, Chief Accounting Officer, Treasurer & VP (Age 57)
  • Ms. Gwendolyn Y. Schreffler M.B.A., Sr. VP of Corp. Devel. & Investor Relations
  • Mr. Mark F. Elvig, Sr. VP, Gen. Counsel & Sec. (Age 62)
  • Mr. Jacobus Schouten, Managing Director (Age 66)
  • J. Donald Dumas Jr., Sr. VP of Production Enhancement & Bus. Devel.

What is David M. Demshur's approval rating as Core Laboratories' CEO?

60 employees have rated Core Laboratories CEO David M. Demshur on Glassdoor.com. David M. Demshur has an approval rating of 36% among Core Laboratories' employees. This puts David M. Demshur in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

Who are some of Core Laboratories' key competitors?

What other stocks do shareholders of Core Laboratories own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Core Laboratories investors own include CA (CA), BlackRock (BLK), Starbucks (SBUX), Micron Technology (MU), Chipotle Mexican Grill (CMG), Endologix (ELGX), Intel (INTC), Netflix (NFLX), AT&T (T) and Gilead Sciences (GILD).

What is Core Laboratories' stock symbol?

Core Laboratories trades on the New York Stock Exchange (NYSE) under the ticker symbol "CLB."

Who are Core Laboratories' major shareholders?

Core Laboratories' stock is owned by a number of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (10.38%), Ariel Investments LLC (10.14%), Van ECK Associates Corp (2.35%), Fisher Asset Management LLC (1.99%), Douglas Lane & Associates LLC (1.50%) and Dimensional Fund Advisors LP (1.42%). Company insiders that own Core Laboratories stock include Gregory Barry Barnett, Jan Willem Sodderland, Kevin Daniels, Lawrence Bruno and Mark F Elvig.
View institutional ownership trends for Core Laboratories
.

Which institutional investors are selling Core Laboratories stock?

CLB stock was sold by a variety of institutional investors in the last quarter, including Truist Financial Corp, C Partners Holding GmbH, Principal Financial Group Inc., Principal Financial Group Inc., Morningstar Investment Services LLC, Renaissance Technologies LLC, Voloridge Investment Management LLC, and Sei Investments Co..
View insider buying and selling activity for Core Laboratories
or view top insider-selling stocks.

Which institutional investors are buying Core Laboratories stock?

CLB stock was purchased by a variety of institutional investors in the last quarter, including Ariel Investments LLC, Norges Bank, Van ECK Associates Corp, Douglas Lane & Associates LLC, BlackRock Inc., Edgestream Partners L.P., Lord Abbett & CO. LLC, and Eaton Vance Management. Company insiders that have bought Core Laboratories stock in the last two years include Gregory Barry Barnett, Jan Willem Sodderland, and Lawrence Bruno.
View insider buying and selling activity for Core Laboratories
or or view top insider-buying stocks.

How do I buy shares of Core Laboratories?

Shares of CLB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Core Laboratories' stock price today?

One share of CLB stock can currently be purchased for approximately $35.82.

How much money does Core Laboratories make?

Core Laboratories has a market capitalization of $1.60 billion and generates $668.21 million in revenue each year. The oil and gas company earns $101.98 million in net income (profit) each year or $1.79 on an earnings per share basis.

How many employees does Core Laboratories have?

Core Laboratories employs 3,700 workers across the globe.

What is Core Laboratories' official website?

The official website for Core Laboratories is www.corelab.com.

Where are Core Laboratories' headquarters?

Core Laboratories is headquartered at STRAWINSKYLAAN 913 TOWER A LEVEL 9, AMSTERDAM P7, 1077 XX.

How can I contact Core Laboratories?

Core Laboratories' mailing address is STRAWINSKYLAAN 913 TOWER A LEVEL 9, AMSTERDAM P7, 1077 XX. The oil and gas company can be reached via phone at 31-20-420-3191 or via email at [email protected]


This page was last updated on 3/7/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.